Benedetta Stancanelli
Overview
Explore the profile of Benedetta Stancanelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regolo M, Sorce A, Vaccaro M, Colaci M, Stancanelli B, Natoli G, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373750
All severe cases of SARS-CoV-2 infections are characterized by a high risk of disease progression towards ARDS, leading to a bad outcome. Respiratory symptoms in COVID-19 patients often do not...
2.
Isaia I, Natoli G, Colaci M, Stancanelli B, Malatino L
Am J Med Sci
. 2022 Apr;
364(3):359-365.
PMID: 35469769
IgG4 related sclerosing cholangitis (IgG4-SC) is a chronic cholestatic autoimmune liver disease, characterized by obstruction of the biliary tract due to IgG4-positive plasma cell infiltrations associated with fibrosis, phlebitis and...
3.
Regolo M, Vaccaro M, Sorce A, Stancanelli B, Colaci M, Natoli G, et al.
J Clin Med
. 2022 Apr;
11(8).
PMID: 35456328
The neutrophil-to-lymphocyte ratio (NLR) is an inflammatory marker predicting the prognosis of several diseases. We aimed to assess its role as a predictor of mortality or admission to the intensive...
4.
Buonacera A, Stancanelli B, Colaci M, Malatino L
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35408994
Over the last 10 years, the evaluation of the neutrophil-to-lymphocyte ratio (NLR) as an emerging marker of diseases has become a compelling field of bio-medical research. Although a precise and...
5.
Buonacera A, Stancanelli B, Malatino L
High Blood Press Cardiovasc Prev
. 2021 Apr;
28(4):331-332.
PMID: 33905096
No abstract available.
6.
Buonacera A, Stancanelli B, Malatino L
Monaldi Arch Chest Dis
. 2018 Jun;
88(2):960.
PMID: 29877671
Despite the effectiveness of anti-hypertensive therapy is well recognized, the most adequate target to achieve in the management of hypertension in the elderly is still under debate. Indeed, looking at...
7.
Cataudella E, Giraffa C, Di Marca S, Pulvirenti A, Stancanelli B, Malatino L
J Am Geriatr Soc
. 2017 Nov;
66(2):418-420.
PMID: 29155451
No abstract available.
8.
Buonacera A, Stancanelli B, Malatino L
Curr Vasc Pharmacol
. 2017 Nov;
17(1):72-84.
PMID: 29149815
Stroke as a cause of long-term disability is a growing public health burden. Therefore, focusing on prevention is important. The most prominent aim of this strategy is to treat modifiable...
9.
Cataudella E, Giraffa C, Di Marca S, Pulvirenti A, Alaimo S, Pisano M, et al.
J Am Geriatr Soc
. 2017 Apr;
65(8):1796-1801.
PMID: 28407209
Objectives: To explore the performance of the neutrophil-to-lymphocyte ratio (NLR), an index of systemic inflammation that predicts prognosis of several diseases, in a cohort of elderly adults with community-acquired pneumonia...
10.
Buonacera A, Stancanelli B, Malatino L
High Blood Press Cardiovasc Prev
. 2017 Apr;
24(3):217-229.
PMID: 28405904
Some tumors are a relatively rare and amendable cause of hypertension, often associated with a higher cardiovascular morbidity and mortality, as compared with that of both general population and patients...